Relation Hba1c with Diabetes Diagnosis

Abstract

The HbA1c test has gained widespread recognition as a reliable and effective biomarker for diagnosing diabetes, offering substantial advantages over traditional methods like fasting blood glucose (FBG). Unlike FBG, which provides a snapshot of glucose levels at a single point in time, HbA1c reflects long-term glycemic control over the past 2-3 months. This paper delves into the relationship between HbA1c levels and diabetes diagnosis, focusing on its diagnostic accuracy, prognostic potential, and clinical utility. It explores how HbA1c serves not only as a diagnostic tool for identifying diabetes but also as a prognostic marker for assessing the risk of diabetes-related complications. Furthermore, the paper highlights the challenges associated with HbA1c testing, such as its susceptibility to interference from factors like anemia and variations in red blood cell turnover, which can affect its accuracy. The need for the standardization of HbA1c testing across different populations and healthcare settings is emphasized, as is the importance of continued improvements in testing methods and technologies to enhance diagnostic precision and overall patient care in diabetes management.